Mark C Genovese

Jun 22, 2023 | futuremedicine.com | Xavier Montalban |Daniel Wallace |Mark C Genovese |Davorka Tomic

Neurodegenerative Disease ManagementAhead of PrintPlain Language Summary of PublicationOpen AccessAbstractWhat is this summary about? This summary explains the findings from a recent investigation that combined the results of over 1000 people from three clinical studies to understand the safety of evobrutinib. Evobrutinib is an oral medication (taken by mouth), being researched as a potential treatment for multiple sclerosis (MS).

Apr 21, 2023 | dovepress.com | Yoshiya Tanaka |Mark C Genovese |Hironori Matsushima

Back to Journals » Patient Preference and Adherence » Volume 17 Authors Tanaka Y , Genovese MC, Matsushima H Received 21 April 2023 Accepted for publication 1 August 2023 Published 6 October 2023 Volume 2023:17 Pages 2499—2516 DOI https://doi.org/10.2147/PPA.S417677 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Johnny Chen Yoshiya Tanaka,1 Mark C Genovese,2,3 Hironori Matsushima4 1The First Department of Internal...